Projection-specific vulnerability to complement-mediated synaptic pruning drives distinct behavioral phenotypes

Target: C1QA Composite Score: 0.000 Price: $0.50 Citation Quality: Pending Perioperative neurocognitive disorders Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
5
Citations
1
Debates
5
Supporting
2
Opposing
Quality Report Card click to collapse
F
Composite: 0.000
Top 50% of 1512 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
F Mech. Plausibility 15% 0.00 Top 50%
B Evidence Strength 15% 0.68 Top 30%
B+ Novelty 12% 0.72 Top 40%
B+ Feasibility 12% 0.78 Top 25%
F Impact 12% 0.00 Top 50%
F Druggability 10% 0.00 Top 50%
F Safety Profile 8% 0.00 Top 50%
F Competition 6% 0.00 Top 50%
F Data Availability 5% 0.00 Top 50%
F Reproducibility 5% 0.00 Top 50%
Evidence
5 supporting | 2 opposing
Citation quality: 44%
Debates
1 session A
Avg quality: 0.83
Convergence
0.00 F 6 related hypothesis share this target

From Analysis:

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety through the same synaptic mechanism?

The study reports that complement-mediated synaptic elimination produces both cognitive deficits and anxiety-like behaviors, but doesn't explain how the same hippocampal synaptic loss generates these distinct behavioral phenotypes. This mechanistic gap limits understanding of perioperative neurocognitive disorders. Gap type: unexplained_observation Source paper: Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors. (2023, BMC Med, PMID:36600274)

→ View full analysis & debate transcript

Description

Prolonged anesthesia triggers complement activation (C1q/C3) that drives microglia-mediated synaptic elimination with projection-specific vulnerability. We hypothesize that ventral hippocampal neurons projecting to prefrontal cortex and amygdala lose synapses preferentially (mediating anxiety through disrupted top-down emotional regulation), while dorsal hippocampal neurons projecting to entorhinal cortex lose synapses preferentially (mediating cognitive deficits through impaired spatial memory encoding). This differential vulnerability is driven by region-specific synaptic molecular signatures (e.g., differential complement regulatory proteins, neuroligin/neurexin variants) that determine susceptibility to microglial C1q recognition and phagocytosis.

...

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.00 (15%) Evidence 0.68 (15%) Novelty 0.72 (12%) Feasibility 0.78 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.000 composite
7 citations 7 with PMID 5 medium Validation: 44% 5 supporting / 2 opposing
For (5)
5
No opposing evidence
(2) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
7
MECH 7CLIN 0GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
PubMed PMID 27033548SupportingMECHPubMed MEDIUM--PMID:27033548-
PubMed PMID 36915214SupportingMECHPubMed MEDIUM--PMID:36915214-
PubMed PMID 22632727SupportingMECHPubMed MEDIUM--PMID:22632727-
PubMed PMID 33558694SupportingMECHPubMed MEDIUM--PMID:33558694-
PubMed PMID 34472455SupportingMECHPubMed MEDIUM--PMID:34472455-
Sevoflurane-induced neurotoxicity can be ameliorat…OpposingMECH- MODERATE--PMID:41168320-
C1q-mediated synaptic elimination is robustly esta…OpposingMECH- MODERATE--PMID:41118244-
Legacy Card View — expandable citation cards

Supporting Evidence 5

PubMed PMID 27033548 MEDIUM
PubMed · PMID:27033548
PubMed PMID 36915214 MEDIUM
PubMed · PMID:36915214
PubMed PMID 22632727 MEDIUM
PubMed · PMID:22632727
PubMed PMID 33558694 MEDIUM
PubMed · PMID:33558694
PubMed PMID 34472455 MEDIUM
PubMed · PMID:34472455

Opposing Evidence 2

Sevoflurane-induced neurotoxicity can be ameliorated by rutin through antioxidant and NF-κB pathway inhibition… MODERATE
Sevoflurane-induced neurotoxicity can be ameliorated by rutin through antioxidant and NF-κB pathway inhibition independent of complement blockade, demonstrating that direct complement-mediated pruning is not the sole mechanism of anesthesia-induced synaptic loss
C1q-mediated synaptic elimination is robustly established during brain development but its role in adult perio… MODERATE
C1q-mediated synaptic elimination is robustly established during brain development but its role in adult perioperative neuroinflammation is mechanistically distinct and less well supported; adult microglial pruning involves alternative complement-independent engulfment pathways (MerTK, TREM2)
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-09 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Based on the knowledge gap regarding how complement-mediated synaptic elimination in the hippocampus produces both cognitive deficits and anxiety-like behaviors, here are my novel therapeutic hypotheses:

Hypothesis 1: Circuit-Specific Complement Targeting

Description: Different hippocampal circuits (CA1-prefrontal for cognition vs CA3-amygdala for anxiety) express distinct complement receptor profiles, making them differentially vulnerable to C1q/C3-mediated elimination. Selective complement inhibition could preserve cognitive circuits while allowing anxiety-related synaptic pruning to

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Now I'll provide my critical evaluation based on the available evidence:

Critical Evaluation of Therapeutic Hypotheses

Hypothesis 1: Circuit-Specific Complement Targeting

Specific Weaknesses:

  • The source paper (PMID:36600274) provides no evidence for distinct complement receptor profiles across hippocampal circuits
  • No data showing differential vulnerability of CA1-prefrontal vs CA3-amygdala pathways
  • Circuit-specific delivery systems for complement inhibitors remain hypothetical with no demonstrated feasibility
Counter-Evidence:
  • Studies show complement activation i

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

PRACTICAL FEASIBILITY ASSESSMENT

Based on my analysis of the provided hypotheses and literature, here's my assessment of druggability and commercial viability:

HYPOTHESIS 6: TEMPORAL COMPLEMENT ACTIVATION WINDOWS

Most Viable - Revised Confidence: 0.45

Druggability Assessment:

HIGH DRUGGABILITY - Complement cascade is well-established drug target
  • C3aR/C5aR antagonists: Multiple small molecules available
  • C1q inhibitors: ANX005 (Annexon Biosciences) - humanized monoclonal antibody
  • C3 inhibitors: Compstatin derivatives (APL-2/Pegcetacoplan, approved for

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

No price history recorded yet

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (7)

No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
Roles of neuropathology-associated reactive astrocytes: a systematic review.
Acta neuropathologica communications (2023) · PMID:36915214
No extracted figures yet
No extracted figures yet
No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.0th percentile (760 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
5

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.050

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

Related Hypotheses

Complement C1q Mimetic Decoy Therapy
Score: 0.695 | neurodegeneration
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.678 | Alzheimer's Disease
Complement C1q Subtype Switching
Score: 0.665 | neurodegeneration
Complement-Mediated Synaptic Pruning Dysregulation
Score: 0.612 | neurodegeneration
Complement-Mediated Synaptic Protection
Score: 0.580 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

3D Protein Structure

🧬 C1QA — PDB 1PK6 Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Why does prolonged anesthesia cause both cognitive dysfunction and anxiety through the same synaptic mechanism?

neurodegeneration | 2026-04-08 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)